Literature DB >> 24658229

Improving accuracy and precision of glucose sensor profiles: retrospective fitting by constrained deconvolution.

Simone Del Favero, Andrea Facchinetti, Giovanni Sparacino, Claudio Cobelli.   

Abstract

Frequent and accurate reference measurements of blood-glucose (BG) concentration are key for modeling and for computing outcome metrics in clinical trials but difficult, invasive, and costly to collect. Continuous glucose monitoring (CGM) is a minimally-invasive technology that has the requested temporal resolution to substitute BG references for such a scope, but still lacks of precision and accuracy. In this paper, we propose an algorithm that retrospectively reconstructs a reliable continuous-time BG profile for the aforementioned purposes, by simultaneously exploiting the high accuracy of (possibly sparse) BG references and the high temporal resolution of CGM data. The algorithm performs a constrained semiblind deconvolution in two steps: first, it estimates the unknown parameters of a model accounting for plasma-interstitum diffusion and sensor inaccurate calibration; then, it estimates BG performing a regularized deconvolution of CGM data, subject to the additional constraint that the reconstructed BG profile has to lay within the confidence interval of the available BG references. The algorithm was tested on 24 datasets collected in a 20 h clinical trial where CGM records and a median of 13 BG samples per day were available. Mean absolute relative deviation was reduced (from 15.71% to 8.84%) with respect to unprocessed CGM and so did the error in the evaluation of the outcomes metrics (e.g., halved the error in the time-in-hypo assessment). The reconstructed BG profile, in view of its improved accuracy and precision, is suitable for clinical trial assessment, modeling and other offline applications.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24658229     DOI: 10.1109/TBME.2013.2293531

Source DB:  PubMed          Journal:  IEEE Trans Biomed Eng        ISSN: 0018-9294            Impact factor:   4.538


  8 in total

1.  Significance and Reliability of MARD for the Accuracy of CGM Systems.

Authors:  Florian Reiterer; Philipp Polterauer; Michael Schoemaker; Guenther Schmelzeisen-Redecker; Guido Freckmann; Lutz Heinemann; Luigi Del Re
Journal:  J Diabetes Sci Technol       Date:  2016-09-25

2.  Insulin Sensitivity Index-Based Optimization of Insulin to Carbohydrate Ratio: In Silico Study Shows Efficacious Protection Against Hypoglycemic Events Caused by Suboptimal Therapy.

Authors:  Michele Schiavon; Chiara Dalla Man; Claudio Cobelli
Journal:  Diabetes Technol Ther       Date:  2018-02       Impact factor: 6.118

3.  Time Delay of CGM Sensors: Relevance, Causes, and Countermeasures.

Authors:  Günther Schmelzeisen-Redeker; Michael Schoemaker; Harald Kirchsteiger; Guido Freckmann; Lutz Heinemann; Luigi Del Re
Journal:  J Diabetes Sci Technol       Date:  2015-08-04

Review 4.  Calibration of Minimally Invasive Continuous Glucose Monitoring Sensors: State-of-The-Art and Current Perspectives.

Authors:  Giada Acciaroli; Martina Vettoretti; Andrea Facchinetti; Giovanni Sparacino
Journal:  Biosensors (Basel)       Date:  2018-03-13

5.  Limits to the Evaluation of the Accuracy of Continuous Glucose Monitoring Systems by Clinical Trials.

Authors:  Patrick Schrangl; Florian Reiterer; Lutz Heinemann; Guido Freckmann; Luigi Del Re
Journal:  Biosensors (Basel)       Date:  2018-05-18

6.  Fluorescent Biocompatible Platinum-Porphyrin-Doped Polymeric Hybrid Particles for Oxygen and Glucose Biosensing.

Authors:  Gaurav Pandey; Rashmi Chaudhari; Bhavana Joshi; Sandeep Choudhary; Jaspreet Kaur; Abhijeet Joshi
Journal:  Sci Rep       Date:  2019-03-22       Impact factor: 4.379

7.  Differences Between Flash Glucose Monitor and Fingerprick Measurements.

Authors:  Odd Martin Staal; Heidi Marie Umbach Hansen; Sverre Christian Christiansen; Anders Lyngvi Fougner; Sven Magnus Carlsen; Øyvind Stavdahl
Journal:  Biosensors (Basel)       Date:  2018-10-17

8.  Implantable and transcutaneous continuous glucose monitoring system: a randomized cross over trial comparing accuracy, efficacy and acceptance.

Authors:  F Boscari; M Vettoretti; F Cavallin; A M L Amato; A Uliana; V Vallone; A Avogaro; A Facchinetti; D Bruttomesso
Journal:  J Endocrinol Invest       Date:  2021-07-01       Impact factor: 4.256

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.